1-2 of 2
Kenjiro Kamiguchi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer

Hiroyuki Hariu, Yoshihiko Hirohashi, Toshihiko Torigoe, Hiroko Asanuma, Midori Hariu, Yasuaki Tamura, Katsuyuki Aketa, Chika Nabeta, Katsuya Nakanishi, Kenjiro Kamiguchi, Yoshinori Mano, Hiroshi Kitamura, Junichi Kobayashi, Tomohide Tsukahara, Noriharu Shijubo, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1000–1009.
https://doi.org/10.1158/1078-0432.1000.11.3
Published: 11 February 2005
View article titled, Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer
Open the PDF for Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer in another window
Journal Articles

An HLA-A24-restricted Cytotoxic T Lymphocyte Epitope of a Tumor-associated Protein, Survivin

Yoshihiko Hirohashi, Toshihiko Torigoe, Akiko Maeda, Yuki Nabeta, Kenjiro Kamiguchi, Takashi Sato, Junichi Yoda, Hideyuki Ikeda, Kouichi Hirata, Noboru Yamanaka, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1731–1739.
Published: 01 June 2002
View article titled, An HLA-A24-restricted Cytotoxic T Lymphocyte Epitope of a Tumor-associated Protein, Survivin
Open the PDF for An HLA-A24-restricted Cytotoxic T Lymphocyte Epitope of a Tumor-associated Protein, Survivin in another window